1Neuroregeneration Institute, McLean Hospital/Harvard Medical School, Belmont, MA 02478, USA.
2Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, and Departments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
3Departments of Neurology, Psychiatry, and Pathology and Cell Biology, Sergievsky Center, Taub Institute and the Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.
4MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
5Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.
6Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
7Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY 14214, USA.
8Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
9University of Florida Shands, Jacksonville, FL 32209, USA.
10Department of Neurology, Medical University of Silesia, Katowice 40-055, Poland.
11Section of Clinical and Molecular Neurogenetics at the Department of Neurology, University of Luebeck, 23562 Luebeck, Germany.
↵§To whom correspondence should be addressed. E-mail: isacson{at}hms.harvard.edu
↵* These authors contributed equally to this work.
eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Servicebefore submitting your own eLetter.
Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease
By Oliver Cooper, Hyemyung Seo, Shaida Andrabi, Cristina Guardia-Laguarta, John Graziotto, Maria Sundberg, Jesse R. McLean, Luis Carrillo-Reid, Zhong Xie, Teresia Osborn, Gunnar Hargus, Michela Deleidi, Tristan Lawson, Helle Bogetofte, Eduardo Perez-Torres, Lorraine Clark, Carol Moskowitz, Joseph Mazzulli, Li Chen, Laura Volpicelli-Daley, Norma Romero, Houbo Jiang, Ryan J. Uitti, Zhigao Huang, Grzegorz Opala, Leslie A. Scarffe, Valina L. Dawson, Christine Klein, Jian Feng, Owen A. Ross, John Q. Trojanowski, Virginia M.-Y. Lee, Karen Marder, D. James Surmeier, Zbigniew K. Wszolek, Serge Przedborski, Dimitri Krainc, Ted M. Dawson, Ole Isacson
Science Translational Medicine : 141ra90
Neural cells derived from induced pluripotent stem cells from patients with genetic forms of Parkinson’s disease provide insights into disease pathogenesis.
Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease
By Oliver Cooper, Hyemyung Seo, Shaida Andrabi, Cristina Guardia-Laguarta, John Graziotto, Maria Sundberg, Jesse R. McLean, Luis Carrillo-Reid, Zhong Xie, Teresia Osborn, Gunnar Hargus, Michela Deleidi, Tristan Lawson, Helle Bogetofte, Eduardo Perez-Torres, Lorraine Clark, Carol Moskowitz, Joseph Mazzulli, Li Chen, Laura Volpicelli-Daley, Norma Romero, Houbo Jiang, Ryan J. Uitti, Zhigao Huang, Grzegorz Opala, Leslie A. Scarffe, Valina L. Dawson, Christine Klein, Jian Feng, Owen A. Ross, John Q. Trojanowski, Virginia M.-Y. Lee, Karen Marder, D. James Surmeier, Zbigniew K. Wszolek, Serge Przedborski, Dimitri Krainc, Ted M. Dawson, Ole Isacson
Science Translational Medicine : 141ra90
Neural cells derived from induced pluripotent stem cells from patients with genetic forms of Parkinson’s disease provide insights into disease pathogenesis.
